Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Scientific Reports|December 16, 2016
Novel platform technology for modular mucosal vaccine that protects against streptococcusMehfuz Zaman, Victoria Ozberk, Emma L Langshaw, et al.
Nanomedicine (London, England)|April 25, 2013
Polymer-peptide hybrids as a highly immunogenic single-dose nanovaccineAbdullah A H Ahmad Fuaad, Zhongfan Jia, Mehfuz Zaman, et al.
Nature Communications|September 25, 2023
A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophilsVictoria Ozberk, Mehfuz Zaman, Ailin Lepletier, et al.
The Journal of Clinical Investigation|July 19, 2013
Cross-species malaria immunity induced by chemically attenuated parasitesMichael F Good, Jennifer M Reiman, I Bibiana Rodriguez, et al.
The Journal of Infectious Diseases|November 22, 2019
Longitudinal Analysis of Group A Streptococcus emm Types and emm Clusters in a High-Prevalence Setting: Relationship between Past and Future InfectionsPatricia Therese Campbell, Steven Y C Tong, Nicholas Geard, et al.
Infection and Immunity|December 23, 2003
Plasminogen binding by group A streptococcal isolates from a region of hyperendemicity for streptococcal skin infection and a high incidence of invasive infectionFiona C McKay, Jason D McArthur, Martina L Sanderson-Smith, et al.
Mbio|June 16, 2016
Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease ModelsTania Rivera-Hernandez, Manisha Pandey, Anna Henningham, et al.
Clinical & Translational Immunology|April 20, 2018
Induction of immunity following vaccination with a chemically attenuated malaria vaccine correlates with persistent antigenic stimulationJennifer M Reiman, Sanjai Kumar, Ingrid B Rodriguez, et al.
Malaria Journal|April 19, 2015
Development of cultured Plasmodium falciparum blood-stage malaria cell banks for early phase in vivo clinical trial assessment of anti-malaria drugs and vaccinesDanielle I Stanisic, Xue Q Liu, Sai Lata De, et al.
Vaccines|April 27, 2024
Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A Streptococcus Pharyngeal Infection in a Non-Human Primate ModelTania Rivera-Hernandez, Diane G Carnathan, Johanna Richter, et al.
Pageof 8